List of Tables
Table 1. Global Pneumococcal Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of PPSV 23
Table 3. Major Manufacturers of PCV 7/13
Table 4. Major Manufacturers of PCV 10
Table 5. Global Pneumococcal Vaccine Market Size Growth Rate by End User, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Pneumococcal Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Pneumococcal Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global Pneumococcal Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 9. Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2024)
Table 10. Global Pneumococcal Vaccine Revenue Market Share by Region (2025-2030)
Table 11. Global Pneumococcal Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Pneumococcal Vaccine Sales by Region (2019-2024) & (K Doses)
Table 13. Global Pneumococcal Vaccine Sales by Region (2025-2030) & (K Doses)
Table 14. Global Pneumococcal Vaccine Sales Market Share by Region (2019-2024)
Table 15. Global Pneumococcal Vaccine Sales Market Share by Region (2025-2030)
Table 16. Global Pneumococcal Vaccine Sales by Manufacturers (2019-2024) & (K Doses)
Table 17. Global Pneumococcal Vaccine Sales Share by Manufacturers (2019-2024)
Table 18. Global Pneumococcal Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 19. Global Pneumococcal Vaccine Revenue Share by Manufacturers (2019-2024)
Table 20. Global Key Players of Pneumococcal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 21. Pneumococcal Vaccine Price by Manufacturers 2019-2024 (USD/Dose)
Table 22. Global Pneumococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Pneumococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccine as of 2023)
Table 24. Global Key Manufacturers of Pneumococcal Vaccine, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Pneumococcal Vaccine, Product Offered and Application
Table 26. Global Key Manufacturers of Pneumococcal Vaccine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 29. Global Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 30. Global Pneumococcal Vaccine Sales Share by Type (2019-2024)
Table 31. Global Pneumococcal Vaccine Sales Share by Type (2025-2030)
Table 32. Global Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 33. Global Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 34. Global Pneumococcal Vaccine Revenue Share by Type (2019-2024)
Table 35. Global Pneumococcal Vaccine Revenue Share by Type (2025-2030)
Table 36. Pneumococcal Vaccine Price by Type (2019-2024) & (USD/Dose)
Table 37. Global Pneumococcal Vaccine Price Forecast by Type (2025-2030) & (USD/Dose)
Table 38. Global Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 39. Global Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 40. Global Pneumococcal Vaccine Sales Share by End User (2019-2024)
Table 41. Global Pneumococcal Vaccine Sales Share by End User (2025-2030)
Table 42. Global Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 43. Global Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 44. Global Pneumococcal Vaccine Revenue Share by End User (2019-2024)
Table 45. Global Pneumococcal Vaccine Revenue Share by End User (2025-2030)
Table 46. Pneumococcal Vaccine Price by End User (2019-2024) & (USD/Dose)
Table 47. Global Pneumococcal Vaccine Price Forecast by End User (2025-2030) & (USD/Dose)
Table 48. US & Canada Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 49. US & Canada Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 50. US & Canada Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 51. US & Canada Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 52. US & Canada Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 53. US & Canada Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 54. US & Canada Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 55. US & Canada Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 56. US & Canada Pneumococcal Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 57. US & Canada Pneumococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 58. US & Canada Pneumococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 59. US & Canada Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 60. US & Canada Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 61. Europe Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 62. Europe Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 63. Europe Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 64. Europe Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 65. Europe Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 66. Europe Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 67. Europe Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 68. Europe Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 69. Europe Pneumococcal Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 70. Europe Pneumococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 71. Europe Pneumococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 72. Europe Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 73. Europe Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 74. China Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 75. China Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 76. China Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 77. China Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 78. China Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 79. China Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 80. China Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 81. China Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 82. Asia Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 83. Asia Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 84. Asia Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 85. Asia Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 86. Asia Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 87. Asia Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 88. Asia Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 89. Asia Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 90. Asia Pneumococcal Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 91. Asia Pneumococcal Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 92. Asia Pneumococcal Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 93. Asia Pneumococcal Vaccine Sales by Region (2019-2024) & (K Doses)
Table 94. Asia Pneumococcal Vaccine Sales by Region (2025-2030) & (K Doses)
Table 95. Middle East, Africa and Latin America Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 96. Middle East, Africa and Latin America Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 97. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 99. Middle East, Africa and Latin America Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 100. Middle East, Africa and Latin America Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)
Table 101. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 104. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 107. Middle East, Africa and Latin America Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 108. Pfizer Company Information
Table 109. Pfizer Description and Major Businesses
Table 110. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 111. Pfizer Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Pfizer Recent Developments
Table 113. GSK Company Information
Table 114. GSK Description and Major Businesses
Table 115. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 116. GSK Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. GSK Recent Developments
Table 118. MSD Company Information
Table 119. MSD Description and Major Businesses
Table 120. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 121. MSD Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. MSD Recent Developments
Table 123. Sanofipasteur Company Information
Table 124. Sanofipasteur Description and Major Businesses
Table 125. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 126. Sanofipasteur Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Sanofipasteur Recent Developments
Table 128. CDIBP Company Information
Table 129. CDIBP Description and Major Businesses
Table 130. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 131. CDIBP Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. CDIBP Recent Developments
Table 133. Key Raw Materials Lists
Table 134. Raw Materials Key Suppliers Lists
Table 135. Pneumococcal Vaccine Distributors List
Table 136. Pneumococcal Vaccine Customers List
Table 137. Pneumococcal Vaccine Market Trends
Table 138. Pneumococcal Vaccine Market Drivers
Table 139. Pneumococcal Vaccine Market Challenges
Table 140. Pneumococcal Vaccine Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Vaccine Product Picture
Figure 2. Global Pneumococcal Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Pneumococcal Vaccine Market Share by Type in 2023 & 2030
Figure 4. PPSV 23 Product Picture
Figure 5. PCV 7/13 Product Picture
Figure 6. PCV 10 Product Picture
Figure 7. Global Pneumococcal Vaccine Market Size Growth Rate by End User, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Pneumococcal Vaccine Market Share by End User in 2023 & 2030
Figure 9. Child
Figure 10. Adult
Figure 11. Pneumococcal Vaccine Report Years Considered
Figure 12. Global Pneumococcal Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Pneumococcal Vaccine Revenue 2019-2030 (US$ Million)
Figure 14. Global Pneumococcal Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 15. Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2030)
Figure 16. Global Pneumococcal Vaccine Sales 2019-2030 ((K Doses)
Figure 17. Global Pneumococcal Vaccine Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 19. US & Canada Pneumococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 20. Europe Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 21. Europe Pneumococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 22. China Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 23. China Pneumococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Asia (excluding China) Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 25. Asia (excluding China) Pneumococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)
Figure 27. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 28. The Pneumococcal Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 29. The Top 5 and 10 Largest Manufacturers of Pneumococcal Vaccine in the World: Market Share by Pneumococcal Vaccine Revenue in 2023
Figure 30. Global Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 31. Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
Figure 32. Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
Figure 33. Global Pneumococcal Vaccine Sales Market Share by End User (2019-2030)
Figure 34. Global Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)
Figure 35. US & Canada Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
Figure 36. US & Canada Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
Figure 37. US & Canada Pneumococcal Vaccine Sales Market Share by End User (2019-2030)
Figure 38. US & Canada Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)
Figure 39. US & Canada Pneumococcal Vaccine Revenue Share by Country (2019-2030)
Figure 40. US & Canada Pneumococcal Vaccine Sales Share by Country (2019-2030)
Figure 41. U.S. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 42. Canada Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 43. Europe Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
Figure 44. Europe Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
Figure 45. Europe Pneumococcal Vaccine Sales Market Share by End User (2019-2030)
Figure 46. Europe Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)
Figure 47. Europe Pneumococcal Vaccine Revenue Share by Country (2019-2030)
Figure 48. Europe Pneumococcal Vaccine Sales Share by Country (2019-2030)
Figure 49. Germany Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 50. France Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 51. U.K. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 52. Italy Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 53. Russia Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 54. China Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
Figure 55. China Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
Figure 56. China Pneumococcal Vaccine Sales Market Share by End User (2019-2030)
Figure 57. China Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)
Figure 58. Asia Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
Figure 59. Asia Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
Figure 60. Asia Pneumococcal Vaccine Sales Market Share by End User (2019-2030)
Figure 61. Asia Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)
Figure 62. Asia Pneumococcal Vaccine Revenue Share by Region (2019-2030)
Figure 63. Asia Pneumococcal Vaccine Sales Share by Region (2019-2030)
Figure 64. Japan Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 65. South Korea Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 66. China Taiwan Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 67. Southeast Asia Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 68. India Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Pneumococcal Vaccine Sales Market Share by End User (2019-2030)
Figure 72. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)
Figure 73. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue Share by Country (2019-2030)
Figure 74. Middle East, Africa and Latin America Pneumococcal Vaccine Sales Share by Country (2019-2030)
Figure 75. Brazil Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 76. Mexico Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 77. Turkey Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 78. Israel Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 79. GCC Countries Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 80. Pneumococcal Vaccine Value Chain
Figure 81. Pneumococcal Vaccine Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed